Article
Effects of Pregnane X Receptor Genetic Polymorphisms on Stable Warfarin Doses.
Journal of cardiovascular pharmacology and therapeutics - 1 Nov 2015
Moon Jung Yeon, Chang Byung Chul, Lee Kyung Eun, Bang Jun Seok, Gwak Hye Sun
Abstract excerpt
OBJECTIVE: Pregnane X receptor (PXR) is a transcriptional regulator of many drug-metabolizing enzymes including cytochrome P450 (CYP) 2C9. The objective of this study was to assess the possible association between PXR single-nucleotide polymorphisms (SNPs) and stable warfarin doses. METHODS: A total of 201 patients with stable warfarin doses from the EwhA-Severance Treatment (EAST) Group of Warfarin were included...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
